GENEVIEVE GROFF: Open Payments
NPI 1578706248 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,429 in 80 payments from 21 companies in 2025. Trend: 2023 $1,096 · 2024 $1,384 · 2025 $1,429
Food & beverage: $1,429
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $260 |
| ABBVIE INC. | 28 | $224 |
| Novo Nordisk Inc | 7 | $148 |
| Eisai Inc. | 5 | $132 |
| Amgen Inc. | 5 | $85 |
| Viatris Specialty LLC | 5 | $84 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| Lilly USA, LLC | 3 | $56 |
| PFIZER INC. | 3 | $52 |
| Abbott Laboratories | 2 | $39 |
Products named: FARXIGA, Leqembi, QULIPTA, KRYSTEXXA, YUPELRI, Ozempic, TRELEGY ELLIPTA, VRAYLAR.
Industry payments across AZ — which companies pay providers there.
